期刊
HEALTH AFFAIRS
卷 34, 期 2, 页码 239-244出版社
PROJECT HOPE
DOI: 10.1377/hlthaff.2014.0983
关键词
-
资金
- Health Policy Investigator Award from the Robert Wood Johnson Foundation
As hard as it may be for clinicians to adopt new practices, it is often harder for them to de-innovate, or give up old practices, even when new evidence reveals that those practices offer little value. In this article we explore recent controversies over screening for breast and prostate cancer and testing for sleep disorders. We show that these controversies are not caused solely by a lack of clinical data on the harms and benefits of these tests but are also influenced by several psychological biases that make it difficult for clinicians to de-innovate. De-innovation could be fostered by making sure that advisory panels and guideline committees include experts who have competing biases; emphasizing evidence over clinical judgment; resisting indication creep, or the premature extension of innovations into unproven areas; and encouraging clinicians to explicitly consider how their experiences bias their interpretations of clinical evidence.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据